공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 체외진단(IVD)용 포장 시장 : 성장, 동향, 예측(2019-2024년)

In-vitro Diagnostics (IVD) Packaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 01월 상품 코드 394601
페이지 정보 영문
가격
US $ 4,250 ₩ 4,803,000 PDF (Single User License)
US $ 4,750 ₩ 5,368,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,781,000 PDF (Site License)
US $ 7,500 ₩ 8,477,000 PDF (Corporate License)


세계의 체외진단(IVD)용 포장 시장 : 성장, 동향, 예측(2019-2024년) In-vitro Diagnostics (IVD) Packaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 01월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 체외진단(IVD : In-vitro Diagnostics)용 포장(Packaging) 시장은 2019-2024년 4.37%의 CAGR로 성장할 것으로 예측됩니다.

세계의 체외진단(IVD)용 포장 시장에 대해 조사했으며, 시장의 기회 및 동향, 성장 및 저해요인, 제품·최종사용자·지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

  • 조사 성과
  • 조사의 가정
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장의 성장 및 저해요인 개요
  • 시장 성장요인
  • 시장 저해요인
  • 업계의 매력 : Porter's Five Forces 분석
    • 신규 진출의 위협
    • 바이어/소비자의 교섭력
    • 공급업체의 교섭력
    • 대체 제품의 위협
    • 경쟁 구도

제5장 시장 세분화

  • 제품별
    • 보틀
    • 바이알
    • 튜브
    • 마개
    • 기타
  • 최종사용자별
    • 병원
    • 연구소
    • 학술기관
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카 지역

제6장 경쟁 구도

  • 기업 개요
    • Amcor Limited
    • Aptargroup Incorporated
    • Corning Incorporated
    • Greiner Holding AG
    • Thermo Fisher Scientific Incorporated
    • COMAR, LLC.
    • WS Packaging Group
    • DWK Life Sciences

제7장 투자 분석

제8장 시장 기회 및 향후 전망

KSA 19.08.13

The In-vitro Diagnostics (IVD) Packaging market was valued at USD 7.10 billion in 2020 and is expected to reach USD 9.23 billion by 2026, at a CAGR of 4.5% over the forecast period (2021 - 2026). The global in vitro diagnostics packaging market is booming mainly due to technological advancements, enhanced diagnostic tools, and increased availability of over-the-counter tests.

  • The rapidly-rising practice of self-testing by the people, an increasing number of point-of-care testing, increased government expenditures on healthcare, growing awareness of personalized medicine, and the increasing number of chronic diseases are some of the major factors boosting the growth of the in vitro diagnostics (IVD) packaging market.
  • The importance of IVD packaging is increasing in the healthcare sector, owing to the demand for faster diagnosis time and increased volume of samples obtained by the automation devices. This has resulted in the increased usage of IVD devices in hospitals.
  • Other contributing factors boosting the growth of the market include the pressure from the governments and industries across the world, to comply with the set regulations, due to the increasing demand for integrated healthcare systems. For instance, the FDA uses a risk-based regulatory scheme for medical devices (including IVDs).

Key Market Trends

Laboratories Segment to Witness High Growth

  • As the hospitals and laboratories are some of the major consumers of in vitro diagnostic devices, the increasing revenues of these sectors are also expected to develop the market for IVD packaging across the world.
  • With the shift from the legacy systems to the commercial solutions favored by the laboratories, the market is expected to grow further as they provide a flexible and reliable method to manage data, resources, and workflows.
  • Many governments across the world are also regulating policies for laboratories having IVDs. For instance, in May 2018, Australia's Therapeutic Goods Administration (TGA) unveiled guidance for laboratories to meet in vitro diagnostics (IVD) regulatory requirements.
  • Moreover, the ongoing shift toward personalized medical devices is expected to create a demand for IVD devices. Also, the innovations in IVD devices are likely to accelerate the demand for IVD packaging during the forecast period.

Asia-Pacific to Witness High Growth

  • The Chinese government is increasing China's healthcare expenditure, primarily to focus on public health. With the increasing number of hospitals in China, it is justifying the investment in public health initiative, which is driving the market in this region.
  • Moreover, Japan has faced the challenges of shrinking and aging population for several years. The latest population estimate by the Health, Labor, and Welfare Ministry, released in December 2018, points to the rapid decline of Japan's population with fewer births. The number of babies born in the country, in 2018, is estimated at 921,000, which is 25,000 less than the previous year and falling short of one million for the third year in a row. These circumstances in the country have accelerated healthcare spending in the region.
  • India is also considered as a lucrative market for generic R&D activities and manufacturing of pharmaceuticals, owing to its strong capabilities across the value chain. Moreover, India's competitive advantage also resides in the magnified success rate of Indian companies in getting the Abbreviated New Drug Application (ANDA) approvals, which is boosting the market growth.

Competitive Landscape

The in vitro diagnostics (IVD) packaging market is competitive due to the presence of many players running their business in both the domestic and international markets. The market is moderately concentrated with the major players adopting strategies, like product innovation and mergers and acquisitions. Some of the major players in the market are Amcor Limited, Aptargroup Incorporated, and Thermo Fisher Scientific Incorporated, among others.

  • June 2019 - Amcor announced the successful completion of its acquisition of Bemis Company Inc. The combined company will now operate as Amcor Plc (Amcor). The acquisition of Bemis brings additional scale, capabilities, and footprint that will strengthen Amcor's industry-leading value proposition.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Introduction to Market Drivers and Restraints
  • 4.3 Market Drivers
    • 4.3.1 Growing Demand for Tubes
    • 4.3.2 Increasing Number of Point-of-care Tests
  • 4.4 Market Restraints
    • 4.4.1 Environmental Concerns Related to Raw Materials for Packaging
  • 4.5 Industry Attractiveness - Porter's Five Force Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers/Consumers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Bottles
    • 5.1.2 Vials
    • 5.1.3 Tubes
    • 5.1.4 Closures
    • 5.1.5 Other Product Types
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Laboratories
    • 5.2.3 Academic Institutes
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.2 Europe
    • 5.3.3 Asia-Pacific
    • 5.3.4 Latin America
    • 5.3.5 Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amcor Limited
    • 6.1.2 Aptargroup Incorporated
    • 6.1.3 Corning Incorporated
    • 6.1.4 Greiner Holding AG
    • 6.1.5 Thermo Fisher Scientific Incorporated
    • 6.1.6 COMAR, LLC.
    • 6.1.7 WS Packaging Group
    • 6.1.8 DWK Life Sciences

7 INVESTMENT ANALYSIS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q